The AMD-treated group showed a significant decrease in the CAT, SOD, and GSH levels in the lung homogenates, resulting in reductions in their CAT, SOD, and GSH values, which were statistically significant compared to the values of the control and sham-operated groups (Figure 5A–C). The gene discussed is SOD1; the disease is age-related macular degeneration.